Home  /  Resource Library  /  Comparative outcomes of lisocabtagene maraleucel versus an external control arm in third-line or later relapsed or refractory follicular lymphoma

Comparative outcomes of lisocabtagene maraleucel versus an external control arm in third-line or later relapsed or refractory follicular lymphoma

Results of a study investigating CAR-T lisocabtagene maraleucel for treatment of relapsed follicular.